For ovarian malignancies, oocyte retrieval is better out of the body
Each year, nearly 100,000 women in the United States are diagnosed with gynecologic malignancies. According to Surveillance, Epidemiology and End Results (SEER) statistics, approximately 12% of ovarian malignancies affect reproductive-age women (1). Although fertility-sparing surgery is an option for women with ovarian cancer with early-stage disease confined to one ovary, the standard treatment typically includes hysterectomy, bilateral salpingo-oophorectomy, staging with pelvic and para-aortic lymphadenectomy, and adjuvant chemotherapy in most cases (2).
Source: fertstert.org
For ovarian malignancies, oocyte retrieval is better out of the body
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Characterization of the stem cell niche components within the seminiferous tubules in testicular biopsies of Klinefelter patients
Be First to Comment